Showing 109 results
-
Media Release /For over two decades, NOYCIA has fueled emerging research in Canada, driving scientific knowledge in cancerMontreal, QC – June 10, 2025 – Novartis Canada is pleased to announce the winners…
-
Media Release /• Applications are now being accepted, with $500,000 in grants to be awarded to projects focused on improving health equity in CanadaMontreal, Quebec, May 14, 2025 – Novartis…
-
Media Release /Novartis has begun collaborating with seven clinics across the province to support the prevention, identification and management of atherosclerotic cardiovascular disease (ASCVD) In Ontario,…
-
Media Release /Fabhalta® is the first oral monotherapy for previously treated and treatment-naïve adults with paroxysmal nocturnal hemoglobinuria (PNH)1,2 Significant unmet need remains in PNH, a chronic, rare…
